EYE vs SPL

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

EYE

NOVA EYE FPO [EYE]

57MEDIUM

SPL

STARPHARMA FPO [SPL]

58MEDIUM

Score Breakdown

EYE SPL
Technical
57
72
Catalyst
53
58
Sentiment
50
50
Fundamental
76
80
Momentum
39
80
Risk Gate
45
50

Key Metrics

EYE Metric SPL
$32.8MMarket Cap$315.7M
269KAvg Volume (20d)794K
N/AShort Interest+0.1%
$0.20552-Week High$0.790
$0.10052-Week Low$0.094
+0.0%Daily Change+5.1%
$0.115Reference Price$0.767
-42.4%ROE-14.5%
-21.3%Profit Margin-22.2%

Active Signals

EYE Signals

MACD momentum is picking up steam
Stochastic is stretched into overbought — could need a breather
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Low cash runway (2 quarters) - dilution risk
Low P/S ratio (1.0x)
Strong revenue growth (+29%)
EPS estimates revised upward (+10pts)

SPL Signals

MACD momentum is picking up steam
Pressing against the upper Bollinger Band — extended and may need to cool off
Trading above both moving averages — the trend is your friend here
Watch out — volume is flowing out even as price holds up. Distribution pattern
Knocking on the door of resistance — if it punches through, things could get interesting
Beating the Small Ords index — relative strength of 1.18, so it's outpacing the pack
Trading above the 200-day average — the long-term trend is on your side
Strong cash runway (86 quarters)

Ask Scout AI to compare EYE and SPL in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

EZZ vs HMD →EZZ vs MEM →EZZ vs MSB →EZZ vs OSL →EZZ vs REG →
EYE Full Analysis → SPL Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).